LAMP2 and breast cancer: Next, to evaluate LAMP2 levels as a diagnostic test for metastatic BC, receiver-operating characteristic analysis was performed including CFC (n = 20), nonmetastatic (M0, n = 24), and metastatic patients (M1, n = 15).